Alitair Pharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ansimar (doxofylline) / ICE GROUP, Alitair Pharma
NCT06346691: Bronchodilator Effect of Oral Doxofylline and Procaterol in Chronic Obstructive Pulmonary Disease : A Randomized Crossover Study

Not yet recruiting
4
20
NA
Doxofylline, Procaterol
Thammasat University
COPD
09/24
12/24
ChiCTR2400080121: Effect of doxofylline on recovery time of propofol: A prospective randomized controlled clinical trial

Not yet recruiting
4
80
 
Doxofylline 2 mg/kg (15 ml) IV postoperatively; Saline 15ml IV postoperatively
Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, self-funded
None
 
 
ChiCTR2400080165: Effect of doxofylline on recovery time of sevoflurane: A prospective randomized controlled clinical trial

Not yet recruiting
4
80
 
Doxofylline 2 mg/kg (15 ml) and sugammadex sodium IV postoperatively; Saline 15ml and sugammadex sodium IV postoperatively
Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, self-funded
None
 
 
ChiCTR2200063105: Effects of ultrasound-guided individualized PEEP combined with doxofylline on the protection of lung function during laparoscopic surgery and postoperative neurocognitive function in patients with COPD

Recruiting
N/A
108
 
conventional high tidal volume ventilation ;PEEP=5cmH2O ;individualized PEEP levels
The Second Affiliated Hospital of Fujian Medical University; The Second Affiliated Hospital of Fujian Medical University, High-level talent cultivation project in the Second Affiliated Hospital of Fujian Medical University, 2022GCC02
Chronic Obstructive Pulmonary Disease (COPD); Cognitive Impairment
 
 
NCT05154942: Vmax Detection of Acupuncture-doxofylline as a Whole Probe of CYP1A in Vivo

Not yet recruiting
N/A
10
NA
DOXO+electroacupuncture
Shanghai Yueyang Integrated Medicine Hospital, Shanghai University of Traditional Chinese Medicine
Acupuncture, Drug Interaction
09/23
11/23
Erdotin (erdosteine) / Recipharm, Alitair Pharma, Daewoong Pharma
2011-000620-14: evalutation of the antitussive effect of Erdosteine in patients with chronic bronchitis Valutazione dell'effetto protettivo verso la tosse esercitato dall'assunzione di Erdosteina nei pazienti con bronchite cronica

Ongoing
4
20
Europe
Capsule, hard, ERDOTIN*30CPS 300MG
AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI, Edmond Pharma
COPD BPCO, chronic bronchitis bronchite cronica, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
ACTRN12624001381572: Feasibility study of 2-weeks of erdosteine used during exacerbations in children with bronchiectasis

Not yet recruiting
3/4
30
 
Queensland University of Technology, Medical Research Future Fund/National Health and Medical Research Council, Queensland Children's Hospital Foundation, Queensland Children's Hospital
Bronchiectasis
 
 
ACTRN12621000315819: BronchiEctasis Trial Testing ERdosteine (BETTER)

Recruiting
3/4
205
 
Queensland University of Technology, Queensland Children's Hospital Foundation, Thrasher Research Fund - EW "Al" Thrasher Award, Medical Research Future Fund/National Health and Medical Research Council
Bronchiectasis
 
 
ACTRN12619000564156: REPEAT: Reducing Exacerbations in people with primary ciliary dyskinesia (PCD) using Erdosteine and Azithromycin Therapy

Completed
3/4
120
 
Menzies School of Health Research, National Health and Medical Research Council - MRFF, Children's Hospital Foundation (Queensland)
primary ciliary dyskinesia
 
 
2008-008529-32: Evaluation of erdosteine effect on systemic inflamation biomarkers during COPD exacerbations

Ongoing
3
40
Europe
ERDOTIN, ERDOTIN
U.O.PNEUMOLOGIA- AZ. USL1 DI MASSA E CARRARA
COPD exacerbation
 
 
2006-005534-20: Effect of Erdosteine on inflammatory and oxidative biomarkers in sputum and exhaled breath in patients with COPD

Ongoing
2
32
Europe
Erdosteine, ERDOTIN, ERDOTIN
Imperial College London
Chronic obstructive pulmonary disease (COPD) of different severity
 
 
ChiCTR2100054291: Formal trial of bioequivalence of erdosteine capsules in healthy subjects in a randomized, open-label, two-dose, single-dose, two-sequence, two-cycle, double-crossover fasted and fed state

Recruiting
N/A
60
 
After fasting for at least 10 hours, take the test preparation (T) erdosteine capsules (Hetan) or the reference preparation (R) erdosteine capsules (ERDOTIN) with 240mL of warm water ;After fasting for at least 10 hours, start eating a high-fat, high-calorie meal 30 minutes before taking the medicine, and consume 100% of it within 30 minutes. Then take the test preparation (T) erdosteine capsules (Hetan) or the reference preparation (R) erdosteine capsules (ERDOTIN) with 240mL warm water
Huzhou Central Hospital; Huzhou Central Hospital, Zhejiang Kangle Pharmaceutical Co., Ltd.
N/A
 
 
benzonatate polacrilex (ALT-02) / Alitair Pharma
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ansimar (doxofylline) / ICE GROUP, Alitair Pharma
NCT06346691: Bronchodilator Effect of Oral Doxofylline and Procaterol in Chronic Obstructive Pulmonary Disease : A Randomized Crossover Study

Not yet recruiting
4
20
NA
Doxofylline, Procaterol
Thammasat University
COPD
09/24
12/24
ChiCTR2400080121: Effect of doxofylline on recovery time of propofol: A prospective randomized controlled clinical trial

Not yet recruiting
4
80
 
Doxofylline 2 mg/kg (15 ml) IV postoperatively; Saline 15ml IV postoperatively
Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, self-funded
None
 
 
ChiCTR2400080165: Effect of doxofylline on recovery time of sevoflurane: A prospective randomized controlled clinical trial

Not yet recruiting
4
80
 
Doxofylline 2 mg/kg (15 ml) and sugammadex sodium IV postoperatively; Saline 15ml and sugammadex sodium IV postoperatively
Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, self-funded
None
 
 
ChiCTR2200063105: Effects of ultrasound-guided individualized PEEP combined with doxofylline on the protection of lung function during laparoscopic surgery and postoperative neurocognitive function in patients with COPD

Recruiting
N/A
108
 
conventional high tidal volume ventilation ;PEEP=5cmH2O ;individualized PEEP levels
The Second Affiliated Hospital of Fujian Medical University; The Second Affiliated Hospital of Fujian Medical University, High-level talent cultivation project in the Second Affiliated Hospital of Fujian Medical University, 2022GCC02
Chronic Obstructive Pulmonary Disease (COPD); Cognitive Impairment
 
 
NCT05154942: Vmax Detection of Acupuncture-doxofylline as a Whole Probe of CYP1A in Vivo

Not yet recruiting
N/A
10
NA
DOXO+electroacupuncture
Shanghai Yueyang Integrated Medicine Hospital, Shanghai University of Traditional Chinese Medicine
Acupuncture, Drug Interaction
09/23
11/23
Erdotin (erdosteine) / Recipharm, Alitair Pharma, Daewoong Pharma
2011-000620-14: evalutation of the antitussive effect of Erdosteine in patients with chronic bronchitis Valutazione dell'effetto protettivo verso la tosse esercitato dall'assunzione di Erdosteina nei pazienti con bronchite cronica

Ongoing
4
20
Europe
Capsule, hard, ERDOTIN*30CPS 300MG
AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI, Edmond Pharma
COPD BPCO, chronic bronchitis bronchite cronica, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
ACTRN12624001381572: Feasibility study of 2-weeks of erdosteine used during exacerbations in children with bronchiectasis

Not yet recruiting
3/4
30
 
Queensland University of Technology, Medical Research Future Fund/National Health and Medical Research Council, Queensland Children's Hospital Foundation, Queensland Children's Hospital
Bronchiectasis
 
 
ACTRN12621000315819: BronchiEctasis Trial Testing ERdosteine (BETTER)

Recruiting
3/4
205
 
Queensland University of Technology, Queensland Children's Hospital Foundation, Thrasher Research Fund - EW "Al" Thrasher Award, Medical Research Future Fund/National Health and Medical Research Council
Bronchiectasis
 
 
ACTRN12619000564156: REPEAT: Reducing Exacerbations in people with primary ciliary dyskinesia (PCD) using Erdosteine and Azithromycin Therapy

Completed
3/4
120
 
Menzies School of Health Research, National Health and Medical Research Council - MRFF, Children's Hospital Foundation (Queensland)
primary ciliary dyskinesia
 
 
2008-008529-32: Evaluation of erdosteine effect on systemic inflamation biomarkers during COPD exacerbations

Ongoing
3
40
Europe
ERDOTIN, ERDOTIN
U.O.PNEUMOLOGIA- AZ. USL1 DI MASSA E CARRARA
COPD exacerbation
 
 
2006-005534-20: Effect of Erdosteine on inflammatory and oxidative biomarkers in sputum and exhaled breath in patients with COPD

Ongoing
2
32
Europe
Erdosteine, ERDOTIN, ERDOTIN
Imperial College London
Chronic obstructive pulmonary disease (COPD) of different severity
 
 
ChiCTR2100054291: Formal trial of bioequivalence of erdosteine capsules in healthy subjects in a randomized, open-label, two-dose, single-dose, two-sequence, two-cycle, double-crossover fasted and fed state

Recruiting
N/A
60
 
After fasting for at least 10 hours, take the test preparation (T) erdosteine capsules (Hetan) or the reference preparation (R) erdosteine capsules (ERDOTIN) with 240mL of warm water ;After fasting for at least 10 hours, start eating a high-fat, high-calorie meal 30 minutes before taking the medicine, and consume 100% of it within 30 minutes. Then take the test preparation (T) erdosteine capsules (Hetan) or the reference preparation (R) erdosteine capsules (ERDOTIN) with 240mL warm water
Huzhou Central Hospital; Huzhou Central Hospital, Zhejiang Kangle Pharmaceutical Co., Ltd.
N/A
 
 
benzonatate polacrilex (ALT-02) / Alitair Pharma
No trials found

Download Options